[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK163910C - OSMOTIC PREPARATION FOR DELIVERING A THERAPEUTIC ACTIVE CONNECTION WITH REGULATED SPEED - Google Patents

OSMOTIC PREPARATION FOR DELIVERING A THERAPEUTIC ACTIVE CONNECTION WITH REGULATED SPEED

Info

Publication number
DK163910C
DK163910C DK099784A DK99784A DK163910C DK 163910 C DK163910 C DK 163910C DK 099784 A DK099784 A DK 099784A DK 99784 A DK99784 A DK 99784A DK 163910 C DK163910 C DK 163910C
Authority
DK
Denmark
Prior art keywords
delivering
active connection
therapeutic active
regulated speed
osmotic preparation
Prior art date
Application number
DK099784A
Other languages
Danish (da)
Other versions
DK163910B (en
DK99784A (en
DK99784D0 (en
Inventor
Patrick S L Wong
Brian Barclay
Joseph C Deters
Felix Theeuwes
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23961585&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK163910(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alza Corp filed Critical Alza Corp
Publication of DK99784D0 publication Critical patent/DK99784D0/en
Publication of DK99784A publication Critical patent/DK99784A/en
Publication of DK163910B publication Critical patent/DK163910B/en
Application granted granted Critical
Publication of DK163910C publication Critical patent/DK163910C/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • External Artificial Organs (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
DK099784A 1983-05-11 1984-02-24 OSMOTIC PREPARATION FOR DELIVERING A THERAPEUTIC ACTIVE CONNECTION WITH REGULATED SPEED DK163910C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49376083A 1983-05-11 1983-05-11
US49376083 1983-05-11

Publications (4)

Publication Number Publication Date
DK99784D0 DK99784D0 (en) 1984-02-24
DK99784A DK99784A (en) 1984-11-12
DK163910B DK163910B (en) 1992-04-21
DK163910C true DK163910C (en) 1992-09-14

Family

ID=23961585

Family Applications (1)

Application Number Title Priority Date Filing Date
DK099784A DK163910C (en) 1983-05-11 1984-02-24 OSMOTIC PREPARATION FOR DELIVERING A THERAPEUTIC ACTIVE CONNECTION WITH REGULATED SPEED

Country Status (20)

Country Link
JP (1) JPS6041609A (en)
AT (1) AT397180B (en)
AU (1) AU566110B2 (en)
BE (1) BE898819A (en)
CA (1) CA1222950A (en)
CH (1) CH669329A5 (en)
DE (1) DE3417113A1 (en)
DK (1) DK163910C (en)
ES (1) ES8503503A1 (en)
FR (1) FR2545721B1 (en)
GB (1) GB2140687B (en)
IE (1) IE56515B1 (en)
IL (1) IL71727A (en)
IT (1) IT1178911B (en)
MX (1) MX163518B (en)
NL (1) NL192250C (en)
NO (1) NO170834C (en)
NZ (1) NZ206600A (en)
SE (1) SE455918B (en)
ZA (1) ZA842422B (en)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH075457B2 (en) * 1983-08-16 1995-01-25 ザ ウエルカム フアウンデ−シヨン リミテツド Pharmaceutical composition allowing the release of the active ingredient in a controlled manner
US4600773A (en) * 1983-12-01 1986-07-15 Eli Lilly And Company Crystalline cephalexin hydrochloride monohydrate
US4624847A (en) * 1985-04-22 1986-11-25 Alza Corporation Drug delivery device for programmed delivery of beneficial drug
ES8800043A1 (en) * 1985-08-16 1987-10-16 Alza Corp Osmotic dispenser
US4963141A (en) * 1985-08-16 1990-10-16 Alza Corporation Dispensing system for administering beneficial agent formulation to ruminants
US4704118A (en) * 1985-08-16 1987-11-03 Alza Corporation Ruminant dispensing device with thermo-activated memory
US4723957A (en) * 1986-02-07 1988-02-09 Alza Corp. System for delivering drug with enhanced bioacceptability
US4716496A (en) * 1986-05-09 1987-12-29 Eaton Corporation Panel-mounted control station housing
US4814181A (en) * 1987-09-03 1989-03-21 Alza Corporation Dosage form comprising fast agent delivery followed by slow agent delivery
US4816263A (en) * 1987-10-02 1989-03-28 Alza Corporation Dosage form for treating cardiovascular diseases comprising isradipine
EP0317780B1 (en) * 1987-11-25 1992-05-20 American Cyanamid Company Sustained (controlled) release delivery system for substituted dihydropyridine calcium channel blockers
US4837111A (en) * 1988-03-21 1989-06-06 Alza Corporation Dosage form for dispensing drug for human therapy
US4855141A (en) * 1988-03-25 1989-08-08 Alza Corporation Device comprising means for protecting and dispensing fluid sensitive medicament
US4859470A (en) * 1988-06-02 1989-08-22 Alza Corporation Dosage form for delivering diltiazem
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
IL91398A (en) * 1988-08-30 1994-05-30 Pfizer Pharmaceutical delivery device comprising active substance surrounded by asymmetric membrane
GR1000270B (en) * 1988-09-30 1992-05-12 Alza Corp Dose for cardiovascular troubles therapy
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Dispensing devices powered by hydrogel
US5030452A (en) * 1989-01-12 1991-07-09 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
US5108756A (en) * 1989-01-12 1992-04-28 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
EP0408496A3 (en) * 1989-07-12 1992-07-01 Ciba-Geigy Ag Solid dosage form for pharmaceutical substances
US4992277A (en) * 1989-08-25 1991-02-12 Schering Corporation Immediate release diltiazem formulation
US5000962A (en) * 1989-08-25 1991-03-19 Schering Corporation Long acting diltiazem formulation
US5067960A (en) * 1989-12-06 1991-11-26 Medtronic, Inc. Muscle fitness detection by colorimetry
US5190763A (en) * 1990-05-07 1993-03-02 Alza Corporation Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
US5081161A (en) * 1990-06-15 1992-01-14 E. I. Du Pont De Nemours And Company Process for making shaped articles of a thermoplastic resin having a microcellular structure
NZ238867A (en) * 1990-07-12 1993-08-26 Alza Corp Dosage form for delayed release comprising pharmaceutically active substance and a drug-release hindering means and a second composition which imbibes fluid, expands, and ejects the active substance from the device
DK0542926T3 (en) * 1990-08-07 1995-05-15 Pfizer Use of interface polymerized membranes in release devices
US5166145A (en) * 1990-09-10 1992-11-24 Alza Corporation Antiemetic therapy
JP2701977B2 (en) * 1990-09-28 1998-01-21 ファイザー インク Dosage form containing hydrophobic medium
US5208037A (en) * 1991-04-22 1993-05-04 Alza Corporation Dosage forms comprising polymers comprising different molecular weights
DE69426997T2 (en) * 1993-02-23 2001-11-15 Heikki Sirkkola The use of a calcium preparation in a medicament for the treatment of dairy cows suffering from hypocalcemia
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US6287598B1 (en) * 1993-05-28 2001-09-11 Alza Corporation Method for providing sustained antiepileptic therapy
HU213407B (en) * 1993-12-09 1997-06-30 Egyt Gyogyszervegyeszeti Gyar Process for producing tablet with diffusive-osmotic release
US5460826A (en) * 1994-06-27 1995-10-24 Alza Corporation Morphine therapy
US5948787A (en) 1997-02-28 1999-09-07 Alza Corporation Compositions containing opiate analgesics
DE19962924A1 (en) 1999-12-24 2001-07-05 Bayer Ag Substituted oxazolidinones and their use
KR101167465B1 (en) * 2000-10-30 2012-07-27 유로-셀티크 소시에떼 아노뉨 Controlled release hydrocodone formulations
US20110104214A1 (en) 2004-04-15 2011-05-05 Purdue Pharma L.P. Once-a-day oxycodone formulations
DE10129725A1 (en) 2001-06-20 2003-01-02 Bayer Ag Combination therapy of substituted oxazolidinones
DE10300111A1 (en) 2003-01-07 2004-07-15 Bayer Healthcare Ag Process for the preparation of 5-chloro-N - ({(5S) -2-oxo-3- [4- (3-oxo-4-morpholinyl) phenyl] -1,3-oxazolidin-5-yl} methyl ) -2-thiophenecarboxamide
US10213387B2 (en) 2003-09-19 2019-02-26 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
WO2005039481A2 (en) * 2003-09-19 2005-05-06 Sun Pharmaceutical Industries Limited Oral drug delivery system
US10226428B2 (en) 2003-09-19 2019-03-12 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
DE10355461A1 (en) 2003-11-27 2005-06-23 Bayer Healthcare Ag Solid, high bioavailabilty oral formulations of N-substituted 5-chloro-2-thiophene-carboxamide derivative in hydrophilized form, useful for combating thrombo-embolic diseases
DE102004062475A1 (en) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Solid, orally administrable, modified release pharmaceutical dosage forms
EP1685841A1 (en) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
DE102005031577A1 (en) 2005-07-06 2007-01-11 Bayer Healthcare Ag Pharmaceutical dosage forms containing a combination of nifedipine and / or nisoldipine and an angiotensin II antagonist
DE102005045518A1 (en) 2005-09-23 2007-03-29 Bayer Healthcare Ag New 5-thienylaminocarbonylmethyl-oxazolidin-2-one derivatives, useful for treating and preventing thromboembolic disease, are selective inhibitors of coagulation factor Xa
JP5416408B2 (en) 2005-10-04 2014-02-12 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 5-chloro-N-({(5S) -2-oxo-3- [4- (3-oxo-4-morpholinyl) -phenyl] -1,3-oxazolidine-5-yl} -methyl) -2- Novel polymorphs and amorphous forms of thiophenecarboxamide.
DE102005047561A1 (en) 2005-10-04 2007-04-05 Bayer Healthcare Ag Drug delivery system, useful to treat and/or prevent e.g. thromboembolic disease, comprises 5-chloro-N-(((5S)-2-oxo-3-(4-(3-oxo-4-morpholinyl)-phenyl)-1,3-oxazolidine-5-yl)-methyl)-2-thiophene carboxamide with fast release active substance
DE102008059206A1 (en) 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmaceutical dosage form containing nifedipine or nisoldipine and an angiotensin II antagonist and / or a diuretic
KR20140069381A (en) * 2009-06-02 2014-06-10 다우 글로벌 테크놀로지스 엘엘씨 Sustained release dosage form
DE102011007272A1 (en) 2011-04-13 2012-10-18 Bayer Pharma Aktiengesellschaft Branched 3-phenylpropionic acid derivatives and their use
BR112014027618A2 (en) 2012-05-07 2017-06-27 Bayer Pharma AG A process for the manufacture of a pharmaceutical dosage form comprising nifedipine and candesartan cilexetil.
UY34856A (en) 2012-07-03 2013-12-31 Bayer Pharma AG PHARMACEUTICAL PRESENTATION FORMS CONTAINING 5-CHLORO-N - ({(5S) -2-OXO-3- [4- (3-OXO-4- MORPHOLINYL) -PHENYL] -1,3-OXAZOLIDIN-5-IL} -METIL) -2-THIOFENCARBOXAMIDE
JP5941117B2 (en) * 2014-10-17 2016-06-29 ダウ グローバル テクノロジーズ エルエルシー Sustained release formulation
JOP20210019A1 (en) 2018-07-24 2021-01-24 Bayer Ag Pharmaceutical dosage form which can be administered orally and has modified release
US10905667B2 (en) 2018-07-24 2021-02-02 Bayer Pharma Aktiengesellschaft Orally administrable modified-release pharmaceutical dosage form
CA3107174A1 (en) 2018-07-24 2020-01-30 Bayer Aktiengesellschaft Pharmaceutical dosage form which can be administered orally and has modified release

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL38538A (en) * 1971-01-13 1974-09-10 Alza Corp Osmotic dispenser
US3977404A (en) * 1975-09-08 1976-08-31 Alza Corporation Osmotic device having microporous reservoir
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4160452A (en) * 1977-04-07 1979-07-10 Alza Corporation Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4265874A (en) * 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4449983A (en) * 1982-03-22 1984-05-22 Alza Corporation Simultaneous delivery of two drugs from unit delivery device

Also Published As

Publication number Publication date
IT8467283A0 (en) 1984-03-23
IL71727A0 (en) 1984-09-30
GB8334189D0 (en) 1984-02-01
DK163910B (en) 1992-04-21
IE840010L (en) 1984-11-11
GB2140687A (en) 1984-12-05
CA1222950A (en) 1987-06-16
NL192250B (en) 1996-12-02
NZ206600A (en) 1987-01-23
NO170834C (en) 1992-12-16
AU2251183A (en) 1984-11-15
IT8467283A1 (en) 1985-09-23
SE8402512L (en) 1984-11-12
SE8402512D0 (en) 1984-05-09
DK99784A (en) 1984-11-12
NL8401470A (en) 1984-12-03
ES532018A0 (en) 1985-03-01
FR2545721B1 (en) 1987-11-06
ES8503503A1 (en) 1985-03-01
DE3417113C2 (en) 1989-02-02
DK99784D0 (en) 1984-02-24
JPH0575725B2 (en) 1993-10-21
SE455918B (en) 1988-08-22
DE3417113A1 (en) 1984-11-15
JPS6041609A (en) 1985-03-05
AT397180B (en) 1994-02-25
MX163518B (en) 1992-05-25
IE56515B1 (en) 1991-08-28
NO840248L (en) 1984-11-12
CH669329A5 (en) 1989-03-15
NL192250C (en) 1997-04-03
IL71727A (en) 1989-01-31
BE898819A (en) 1984-05-30
ATA88084A (en) 1993-07-15
FR2545721A1 (en) 1984-11-16
IT1178911B (en) 1987-09-16
GB2140687B (en) 1987-03-18
ZA842422B (en) 1984-11-28
NO170834B (en) 1992-09-07
AU566110B2 (en) 1987-10-08

Similar Documents

Publication Publication Date Title
DK163910C (en) OSMOTIC PREPARATION FOR DELIVERING A THERAPEUTIC ACTIVE CONNECTION WITH REGULATED SPEED
DK477184D0 (en) SYSTEM FOR DELIVERING A THERAPEUTIC AGENT IN THE ORAL
DK365382A (en) PROCEDURE FOR PREPARING A DOSAGE CONTROL WITH CONTROLLED DELIVERY
DK151786D0 (en) DEVICE FOR DELIVERING HAMBLE GAS TO A PATIENT
ES549639A0 (en) OSMOTIC DEVICE FOR THE CONTROLLED ADMINISTRATION OF A BENEFICIAL AGENT TO A USE ENVIRONMENT
DK16487D0 (en) VACCINES FOR ORAL ADMINISTRATION
DK410787D0 (en) ORAL THERAPEUTIC SYSTEM WITH SYSTEMIC EFFECT
NO157869C (en) DENTAL WITH A DEVICE FOR ATTACHING TO THE EDGE OF AN EXCHANGE MACHINE E.L.
ES557146A0 (en) A DEVICE TO AUTOMATICALLY FOLLOW A TARGET
DK50191D0 (en) ORAL PHARMACEUTICAL PREPARATIONS WITH COLONS SELECTIVE DELIVERY
BR8602579A (en) METHOD TO PRODUCE A DRIP IRRIGATION LINE AND EMITTER FOR DRIP IRRIGATION LINE
DK166479C (en) USE OF FLUOXETIN, NORFLUOXETIN OR A PHARMACEUTICAL ACCEPTABLE SALT OF FLUOXETIN OR NORFLUOXETIN FOR THE PREPARATION OF A MEDICINE WITH ANXIOLYTICAL EFFECT
DK408884A (en) PREPARED FOR A SUBSIDIARY PROJECT
BR7900319A (en) CONTROLLER FOR PREVENTING EXCESS SPEED IN A TURBINE SYSTEM
DK485688D0 (en) DOSAGE FORM TO DELIVER DILTIAZEM
DK246984A (en) DIHYDROBENZOPYRROLOBENZODIAZEPINES A PROCEDURE FOR THEIR PREPARATION AND THEIR USE AS MEDICINES
DK155082A (en) PROCEDURE FOR THE PREPARATION OF A PREPARATION WITH CYTOTOXIC EFFECT
IT1204820B (en) PERFECTED DEVICE FOR HEMOFILTRATION
DK467086D0 (en) DEVICE FOR INJECTING A CHEESE CASE
GB8319546D0 (en) Pharmaceutical active salts
DK131884D0 (en) PHARMACEUTICAL AGENTS WITH ANTINEOPLASTIC EFFECT
DK201884A (en) PHARMACEUTICAL PREPARATION WITH ANTI-HYPERTENSIVE EFFECT
DK586284D0 (en) QUINOLONCARBOXYLIC ACID DERIVATIVES, PROCEDURES FOR PREPARING THEREOF AND USING SUCH DERIVATIVES AS MEDICINAL
NO864320D0 (en) RESIN MIXTURE AXIBLE FOR AA RELEASES A BIOACTIVE SUBSTANCE WITH CONTROLLED SPEED.
DK249083D0 (en) METHOD OF PREPARING A PHARMACEUTICAL PREPARATION FOR THE ADMINISTRATION OF ANTI-ANDROGENT ACTIVE COMPOUNDS

Legal Events

Date Code Title Description
PUP Patent expired